Podcasts about women's health initiative

Dr. Dee Dlugonski earned her undergraduate degree in Kinesiology from Penn State University where she was a nine-time All-American swimmer and a member of two Big Ten Championship teams in 2002 and 2005. After graduating, she coached swimming at the University of Connecticut and Penn State before returning to school to earn her PhD in Kinesiology from the University of Illinois. Dee’s research focuses on physical activity promotion among women, children, and families. She brings her expertise as an athlete, a coach, and a researcher to current role as the Coordinator of the Active Women’s Health Initiative at the University of Kentucky.

Join Us as we discuss the importance of prioritizing Women's Pregnancy Healthcare in the Black Community. Listen in as Natrina shares her plans for her "WHI" Non Profit Organization

Dr. Heather Hirsch, who leads the Menopause and Midlife Clinic at Brigham and Women's Hospital, breaks down what women should expect as they go through menopause. We discuss estrogen replacement therapy, hot flashes, changes in metabolism during menopause, and the Women's Health Initiative. Hirsch also explains how cognitive behavioral therapy can be beneficial when dealing with the symptoms that arise during the menopausal transition.

SHR # 2446 :: BEST OF: Hormonal Contraceptive And Multiple Sclerosis Susceptibility PLUS Effects Of HRT On Cerebral Function In Postmenopausal Women At Risk Of Dementia PLUS Genetic Dysbiosis: The Role Of Microbial Insults In Chronic Inflammation - Guest: Dr. Annette Langer-Gould - Dr. Natalie Rasgon - Dr. Luigi Nibali - This show originally aired in April of 2014. Multiple Sclerosis is on the rise in women. Dr. Langer-Gould's group looked at the linkage between hormonal contraceptives and the prevalence of Multiple Sclerosis. PLUS Dr. Rasgon's group looked at brain function, metabolism and cognition in a group of postmenopausal women who are genetically predisposed to dementia. They compared those who are currently on HRT and those who were on and stopped. They also corrected for those using beta-estradiol, beta-estradiol and progesterone combined and compared to those using Conjugated Equine Estrogen as well as synthetic estrogen and progestins. The results was astounding and explains why the Women's Health Initiative study was a complete failure and ultimately hurt a lot of women. PLUS Many of us are aware of the importance of the microbiome in our body. But what if you can't influence it through the introduction of beneficial microbes? What if your genetics predispose you to specific phyla of microbes and not others. And THIS is the real "genetic predisposition" to developing diseases like Irritable Bowel Syndrome, Rheumatoid Arthritis, Cancer and more. Dr. Nibali's group may have discovered that its your genes that allow your body to adopt some microbes while not others.

In 2002, the Women's Health Initiative released the results of its study, claiming use of Hormone Replacement Therapy (HRT) increased a woman's risk of breast cancer. Almost overnight, use plummeted, leaving a great many women without a good alternative for managing their menopause symptoms. In their book Estrogen Matters, Dr. Avrum Bluming and Dr. Carol Tavris take a deep and detailed look at the WHI study and its conclusions. Not only, they argue, did the WHI unnecessarily frighten women and leave them suffering with very real symptoms, they may also have prevented women from taking a life-changing, even life-prolonging treatment. In this podcast with genneve CEO Jill Angelo and genneve Director of Health ob/gyn Dr. Rebecca Dunsmoor-Su, Drs. Tavris and Bluming take us through their research and make a compelling case for the safety and effectiveness of HRT. If you're in or approaching menopause, this podcast and the book Estrogen Matters can help you better understand HRT, its true risks, and the very real benefits it can offer. Learn more and find the full transcript at genneve.com.

Dr. Mark Menolascino is the medical director of the Meno Clinic Center for Functional Medicine and has over 25 years of healthcare experience. In today's podcast episode, he talks with JJ about a topic that deserves much more attention: heart disease in women! Listen as Dr. Menolascino explains why cardiovascular disease in females is under-addressed in mainstream medicine and how his approach differs from that of conventional healthcare providers. Dr. Menolascino also shares the most important tests you should be asking for to help identify your level of risk, as well as his top tips on how to choose the best eating plan for your heart health. His new book, Heart Solution for Women, provides a comprehensive approach to preventing and reversing heart disease!   Freebies From Today’s Episode Get Dr. Mark Menolascino’s free Heart Solution webinar by going to JJVirgin.com/heartsolution.   Main Points From Today’s Episode Heart disease is the number one killer of women in the United States. In fact, more women die of heart disease than all cancers combined. Results from the Women's Health Initiative showed that cholesterol drugs don't benefit women at all when it comes to stroke prevention. In addition, the study found that the risk of getting type 2 diabetes from taking cholesterol medication was over 50% in post-menopausal women. Dr. Menolascino's book, Heart Solution for Women, provides a proven approach to preventing and reversing heart disease. Dr. Menolascino believes it's important to personalize diagnostic strategies and treatment therapies for women.   Episode Play-By-Play [1:34] Dr. Mark Menolascino’s career briefing [4:21] How Dr. Menolascino become an expert in heart disease [5:15] Why doesn’t heart disease in women get the attention it deserves? [6:15] Results from the Women’s Health Initiative [7:20] How is Dr. Menolascino’s approach different than that of conventional medicine? [8:05] Dr. Menolascino recommends starting with the right blood tests. [8:56] Why stress tests should also be done with imaging [9:37] What is a Carotid Intima-Media Thickness Test? [10:20] The symphony of female hormones [11:15] It’s key to find a doctor who knows how to look at you as an individual. [13:20] How to choose the best eating plan to prevent and reverse heart disease [15:50] Figuring out which foods are inflammatory for you [17:36] The importance of community [18:45] The future of medicine for women [20:37] For most chronic illnesses, the acute-care model doesn’t work very well. [22:35] Ready to lose fat fast and keep it off forever? Discover the number one resource for fast and lasting fat loss by visiting jjvirgin.com! [23:12] Listener shout-out [26:19] Listener’s question: I’ve been told that if I don’t get my LDL cholesterol down, I’m going to need to start taking a statin drug. What should I do?   Mentioned in this episode: Heart Solution for Women: A Proven Program to Prevent and Reverse Heart Disease, by Dr. Mark Menolascino JJ Virgin 7-Day Stop, Drop & Swap Challenge Direct-to-Consumer Lab Testing The Institute for Functional Medicine’s Find a Practitioner tool Become part of JJ’s community JJ Virgin Official Facebook page JJ Virgin on Instagram JJ Virgin on YouTube

In this episode, Avrum Bluming, hematologist, medical oncologist, and emeritus clinical professor at USC and Carol Tavris, social psychologist and author of Mistakes Were Made (But Not By Me), discuss their collaboration on their recent book, Estrogen Matters. Their book takes on the very polarizing and confusing topic of hormone replacement therapy for women suffering with symptoms of menopause. In many ways, the story and history of HRT is in striking parallel to the bad science that led up to the dietary guidelines being set forth in 1980. Carol and Avrum make a compelling case that most women benefit greatly from being on postmenopausal hormone replacement therapy, and can do so without increasing their risk of breast cancer. We also cover the history of HRT, the impact of the Women's Health Initiative, and take a deep dive into each of the clinical conditions for which HRT should be considered, such as cardiovascular disease, neurodegenerative disease, and osteoporosis, to name a few. We discuss: The background of Carol and Avrum, and the impetus for writing Estrogen Matters [8:45]; The sad early history of hormone replacement therapy, treatments for prostate and breast cancer, and the difference between the treatment of women vs. men [14:00]; What hormones do, and why they drop off rapidly in women compared to gradually in men [20:15]; Mistreatment of women leading to great skepticism [23:45]; Breast cancer vs heart disease: Comparing the incidence and mortality in women [27:00]; Case studies of women suffering symptoms of menopause [30:00]; What are Carol and Avrum’s true motivations in this endeavor? [32:45]; The changing perceptions of HRT, the impact of the Women’s Health Initiative (WHI), and the problems with the WHI [37:45]; Is this one big conspiracy? The uncanny resemblance of the story of HRT and how the dietary guidelines were created [46:00]; Why people (falsely) think estrogen causes a 25% increase in breast cancer, and a lesson in absolute vs. relative risk [57:15]; The truth about progesterone and cancer risk, and the best types of estrogen and progesterone to be taking [1:09:00]; The Women’s Health Initiative: the reported findings, walking back their bold claims, and their hesitance to admit they were wrong [1:17:45]; Brain benefits of HRT, Alzheimer’s disease in women, and estrogen as a preventative treatment for AD [1:22:45]; The impact of HRT on heart disease, the ideal time to start HRT, and the risks associated with HRT [1:26:45]; The benefits of estrogen on bone health, and the incidence and mortality of hip fractures [1:33:15]; Colon cancer: Can HRT reduce the risk of colon cancer? [1:38:15]; Diabetes: Can HRT reduce the risk of developing diabetes? [1:40:30]; The downsides of hormone replacement therapy (HRT) [1:41:30]; How to approach your doctor who may already have a very strong point of view about HRT [1:42:15]; What kind of research needs to be done to answer the remaining questions about the benefits and risks of HRT? [1:48:30]; Cancer: Our evolving understanding and the future of treatment [1:59:15]; Welcoming the critics: Avrum and Carol want to start a conversation [2:02:00]; Are there racial differences in benefits and risks with HRT? [2:04:15]; The reactions to Estrogen Matters, and why it is a must read [2:09:15]; HRT after a diagnosis of breast cancer [2:13:45]; and More. Learn more at www.PeterAttiaMD.com Connect with Peter on Facebook | Twitter | Instagram.

Happy New Year! Nick and Fei are back again with Dr. Eger. This time, we talk about the treatment of vasomotor symptoms of menopause and the Women's Health Initiative.  More information will be posted on our website: www.creogsovercoffee.com  Come check us out on Twitter: @creogsovercoff1 Questions about our podcast or have topics you'd like to contribute? Email us at: creogsovercoffee@gmail.com 

Mentioned in the Show Ancel Keys (https://www.sevencountriesstudy.com/about-the-study/investigators/ancel-keys/) Kerrygold Butter (http://www.kerrygold.co.uk) Women's Health Initiative (https://www.whi.org/SitePages/WHI%20Home.aspx) Elle Russ Book (http://amzn.to/2FQhf15) Ken's Book, Lies My Doctor Told Me (http://amzn.to/2DllGDn) Connect with Ken Website (https://www.kendberrymd.com) Facebook (http://www.facebook.com/kendberry.md) Youtube (http://www.youtube.com/kendberrymd) Instagram (http://www.instagram.com/kendberry.md) Website (https://www.theberryclinic.com) Note if you are looking at this in Apple Podcasts, not all links are active. Head on over to the site below for full details https://bbb.fireside.fm/episodes Connect with Me If you enjoy the show please leave a review on iTunes, I would love it! iTunes Review (https://itunes.apple.com/gb/podcast/building-a-better-body/id1192279512?mt=2) Send Listener Questions to: info@karenmcclintock.co.uk Support The Show (https://karenmcclintock.co.uk/support/) My Social Media: Facebook (https://www.facebook.com/buildingabetterbodypodcast) Instagram (https://www.instagram.com/buildingabetterbodypodcast) Website (http://www.karenmcclintock.co.uk) Special Guest: Dr Ken Berry.

Authors: Cynthia A. Thomson, Tracy E. Crane, David O. Garcia, Betsy C. Wertheim, Melanie Hingle, Linda Snetselaar, Mridul Datta, Thomas Rohan, Erin LeBlanc, Rowan T. Chlebowski, and Lihong Qi Video: Researchers looked at dietary energy density (DED) in the diets of post-menopausal women using data from the Women's Health Initiative and discovered that consuming high DED foods was tied to a 10% increase in obesity-related cancer among normal weight women.(http://dx.doi.org/10.1016/j.jand.2017.06.010)

Becky Freeman, TC's Assistant Editor; Web & New Media, talks to Andrew Hyland, Roswell Park Cancer Institute, Buffalo, about his paper looking at the associations between tobacco exposure and adverse pregnancy outcomes. Read the full paper: Associations of lifetime active and passive smoking with spontaneous abortion, stillbirth and tubal ectopic pregnancy: a cross-sectional analysis of historical data from the Women's Health Initiative http://goo.gl/IM1Keh

Summary of the May 6, 2014 issue, including articles on changes in mortality rates after the Massachusetts health care reform, economic return from the Women's Health Initiative estrogen plus progestin trial, and cardiac resynchronization therapy; updates in pulmonary, sleep, and critical care medicine and women's health; the evidence review and USPSTF recommendation statement on illicit drug use and nonmedical pharmaceutical use in children and adolescents; commentaries on medical education and patient safety measures; as well as an article on using social media to evaluate clinical data and management protocols during the Syrian sarin attack.

Bioidentical Hormone Therapy means that the exact molecule in the product is identical in structure to the hormone produced in our body's glands. These bioidentical hormones can be made into creams, capsules, gels, sublingual lozenges, sublingual drops and subcutaneous implantable pellets at a compounding pharmacy.   Pharmaceutical companies make synthetic hormones that are not structurally the same as what our body produces. These chemicals have been altered by attaching a group to the compound therefore making man-made chemicals that can be patented. It is possible to find bioidentical hormones that are made by pharmaceutical companies and they do this by patenting their delivery system since bioidentical hormones themselves cannot be patented.   For example, estriol or estradiol can be found in a patch form for women. Testosterone can be found in a gel form. This is how the pharmaceutical company delivers a bioidentical hormone in a patented delivery form. The molecule itself is not patented, only the delivery system.   The Women's Health Initiative and the HERS Study both showed that the synthetic form of progesterone called medoxyprogesterone acetate caused thin women to have an increase in breast cancer, ovarian cancer, heart attack and stroke. After these two studies, an enormous amount of women stopped taking Prempro and Provera. But they still continued to experience symptoms of progesterone and estrogen deficiency. Women are actively seeking information on bioidentical hormone therapy and they want answers.   Please see the video Why Hormones Are Not Enough to learn more about how it is necessary to supply your body with the proper nutrients so that your body is able to produce the hormones required for your body to function properly.   by Robert Seik, PharmD

Interview with JoAnn E. Manson, MD, author of Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women's Health Initiative Randomized Trials

Dr.  Eno is a board certified Internal Medicine Physician and Professional Life Coach with a passion for enhancing the health and wellbeing of today's 21st century woman. She's back with a brand new format to her blog talk radio program. Join her for her Saturday noontime wellbeing roundup in which she summarizes top health and wellness issues of the week in addition to recommendations and tips on how to enhance your health and wellbeing.  Designed to be not only informative but highly interactive this is your opportunity to connect with Dr Eno and suggest topics or even ask her questions. For more information on Dr Eno please log onto her website www.askdoctorneno.com In this episode Dr Eno discusses atrial fibrillation. What it is. How it's diagnosed and also recent findings from the Women's Health Initiative about how hormone replacement therapy has been recently related to atrial fibrillation.

Dr.  Eno is a board certified Internal Medicine Physician and Professional Life Coach with a passion for enhancing the health and wellbeing of today's 21st century woman. She's back with a brand new format to her blog talk radio program. Join her for her Saturday noontime wellbeing roundup in which she summarizes top health and wellness issues of the week in addition to recommendations and tips on how to enhance your health and wellbeing.  Designed to be not only informative but highly interactive this is your opportunity to connect with Dr Eno and suggest topics or even ask her questions. For more information on Dr Eno please log onto her website www.askdoctorneno.com In this episode Dr Eno discusses atrial fibrillation. What it is. How it's diagnosed and also recent findings from the Women's Health Initiative about how hormone replacement therapy has been recently related to atrial fibrillation.

Guest: Eliot Brinton, MD, FAHA, FNLA Host: Larry Kaskel, MD The Women's Health Initiative trial reported that hormone replacement therapy increases the risks of coronary artery disease in postmenopausal women. Dr. Eliot Brinton, director of the metabolism section of the cardiovascular genetics department at the University of Utah School of Medicine in Salt Lake City, and a founding board member of the National Lipid Association and the American Board of Clinical Lipidology, discusses with host Dr. Larry Kaskel a new analysis of the Women's Health Initiative that disputes these findings. Dr. Brinton explores the various risks associated with estrogen, provides guidance on how to evaluate the use of estrogen in postmenopausal women, as well as the practice of stopping estrogen. Tune in to hear Dr. Brinton identify the evidence that supports the cardio-protective effects of estrogen as well the relationship between stroke and estrogen use. Brought to you by: